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Key Points 
Question 
Can single-channel electrocardiogram (ECG) - derived heart rate variability (HRV) 
recorded in toddlers yield a biomarker of fetal in utero exposure to Zika virus? 
Findings 
Grid Count measure of HRV serves as the best ECG-derived biomarker of fetal 
exposure to Zika virus infection with high classification performance. 
Meaning 
It is feasible to measure HRV in infants and toddlers using a small non-invasive 
portable ECG device. Such screening approach may uncover memory of in utero 
exposure to ZIKV. 
  
Abstract 
Although Zika virus (ZIKV) seems to be prominently neurotropic, there are some 
reports of involvement of other organs, particularly the heart. Of special concern are 
those children exposed prenatally to ZIKV and born with no microcephaly or other 
congenital anomaly. Electrocardiogram (ECG) - derived heart rate variability (HRV) 
metrics represent an attractive, low cost, widely deployable tool for early identification 
of such children. We hypothesized that HRV in such children would yield a biomarker 
of fetal ZIKV exposure. We investigated the HRV properties of 21 infants aged 4 to 25 
months from Brazil. The infants were divided in two groups, the ZIKV-exposed (n=13) 
and controls (n=8). Single channel ECG was recorded in each child at ~15 months of 
age and HRV was analyzed in 5 min segments to provide a comprehensive 
characterization of the degree of variability and complexity of the heart rate. Using a 
cubic Support Vector Machine (SVM) classifier we identified babies as Zika cases or 
controls with negative predictive value of 92% and positive predictive value of 86%. 
Our results show that HRV metrics can help differentiate between ZIKV-affected, yet 
asymptomatic, and non-ZIKV exposed babies. We identified the Grid Count as the best 
HRV measure in this study allowing such differentiation, regardless the presence of 
microcephaly. We show that it is feasible to measure HRV in infants and toddlers using 
a small non-invasive portable ECG device and that such approach may uncover 
memory of in utero exposure to ZIKV. This approach may be useful for future studies 
and low-cost screening tools involving this challenging to examine population.  
  
Introduction 
The sudden outbreak of children being born with microcephaly in Brazil in 2015 led to 
the identification of a new teratogen in humans: the Zika Virus (ZIKV).1,2  A specific 
pattern of “Fetal Brain Disruption Sequence” 3 with small skull and pronounced 
craniofacial disproportion, overlapping cranial sutures, occipital prominence and 
redundant skin in the head and neck, joint contractures, and severe neurological 
impairments was described, and brain imaging (CT scan or MRI) presenting multiple 
calcifications, poor and abnormal gyral patterns, increased intracranial fluid, and 
cortical destruction. 4,5  However, there is a spectrum of less severe abnormalities after 
congenital ZIKV exposure with a range of abnormalities including postnatal 
microcephaly, hydrocephaly, brain calcifications, ophthalmic abnormalities, seizures 
and other neurological dysfunctions.6–8  
Although ZIKV seems to be prominently neurotropic, there are some reports of 
involvement of other organs, particularly the heart. Cavalcanti et al. found 14/103 
(13.5%) Brazilian children with congenital zika syndrome (CZS) to present with 
echocardiograms compatible with congenital heart disease.9 Most of them, however, 
were septal defects with no hemodynamic significance. Similarly, Orofino et al. 
reported 13/97 (10.8%) major cardiac defects (atrial septal defect, ventricular septal 
defect, patent ductus arteriosus) on echocardiographic exams in infants with confirmed 
ZIKV exposure.10 None of the defects were severe. 
Of special concern are those children exposed prenatally to ZIKV born with no 
microcephaly or other congenital anomaly at birth. Electrocardiogram (ECG) - derived 
heart rate variability (HRV) metrics represent an attractive, low cost, widely deployable 
tool for early identification of such children.  
We hypothesized that ECG-derived HRV in such children would yield a biomarker of 
fetal ZIKV exposure.   
Methods 
We investigated the HRV properties of 21 infants aged 4 to 25 months from Brazil. The 
study was approved by the local Ethics Board (CAAE: 56176616.2.1001.5327). This 
was a convenience sample from a group of children being followed by us according to 
the guidelines of the Surveillance and Response Protocol published by the Brazilian 
Ministry of Health.11 All participants provided full written informed consent for data 
collection and registration.  
 
Congenital infections were diagnosed using the following criteria: 1) ZIKV: confirmed 
by maternal polymerase chain reaction (PCR) result (in blood) consistent with Zika 
virus disease during pregnancy;.2) CMV: confirmed by positive PCR in urine of the 
baby. 
The infants were divided in two groups, the ZIKV-exposed and controls: (1) Group with 
ZIKV maternal infection during pregnancy (n=13) and (2) a control group (n=8) of 
children with other diagnoses reported to authorities due to microcephaly (4 congenital 
infection, 1 genetic syndrome, 1 small for gestational age – normal development; 2 
normal infants). In the exposed group, two were diagnosed with CZS with severe 
microcephaly. The remaining 11 children were born with normal head circumference 
(HC), but to mothers with RT-PCR confirmed ZIKV infection during pregnancy (n=9) or 
probable ZIKV infection by clinical/epidemiological criteria (n=2). Symptoms of ZIKV in 
this sample were in the first trimester of pregnancy (n=3); second (n=6) and third (n=4). 
Single channel ECG was recorded in each child at ~15 months of age using the Zephyr 
device (Zephyr Technology Corporation, Annapolis, MD) for 20 minutes on average. 
Recording was performed in the morning, before the clinical examination with the baby 
held by the mother in the upright position. Baby/infant was calm and awake. We 
excluded children who got too agitated or with excessive crying. 
HRV analysis: R-peaks were extracted automatically from the ECG recordings in order 
to create R-peak to R-peak interval time series. The R-peak locations were visually 
inspected to make sure the detection algorithm worked correctly. Noisy portions 
(saturated, very noisy periods) were discarded from the subsequent analysis. 
On average, around 15 minutes of ECG recordings were usable for the HRV analysis. 
The HRV analysis was done using 5 min moving windows and 2.5 min overlap and a 
set of 54 variability metrics were calculated for each 5 min window, in order to provide 
a comprehensive characterization of the degree of variability and complexity of the 
heart rate.12,13 Each variability metric time series was then averaged over all 5 min 
windows. 
Classification: A cubic Support Vector Machine (SVM) classifier was used to classify 
babies as Zika cases or controls. The SVM kernel was scaled automatically and we 
used a regularization factor of 1. A 100 repeat, 5-fold cross-validation process was 
used to select the best single variability metric and estimate the performance the cubic 
SVM classifier on the 20 subjects to estimate classification performance. A single 
metric was selected due to the limited sample size. 
Both HRV processing and classification were implemented in Matlab R2016b 
(Mathworks Inc.).   
  
Results 
The clinical characteristics of the cohort are summarized in the Table 1. As expected, 
the number of cases with microcephaly, but not head circumference, was lower in the 
ZIKV group compared to controls. There were more younger infants in the ZIKV group 
during the ECG recording than in the control group. Other characteristics were similar. 
The best HRV metric was the Grid Count, a complexity metric derived from a grid 
transformation of a dynamical system trajectory.14 Results in the following Table 2 are 
averaged over all repeats/folds of the cross-validation process. Fig. 1 shows that Grid 
Count measure of HRV for these two babies was within the range of other ZIKV-group 
subjects. Excluding the two ZIKV-babies with microcephaly did not change these 
findings.  
 
Discussion 
Our results show that HRV metrics can help differentiate between ZIKV-affected, yet 
asymptomatic, and non-ZIKV exposed babies. We identified the Grid Count as the best 
HRV measure in this study allowing such differentiation, regardless the presence of 
microcephaly. Future studies including a larger sample size will permit to possibly 
identify an even more precise subset of HRV measures with regard to ability to 
differentiate between ZIKV-exposed babies and controls.  
Our finding aligns with the recently published study in ex vivo fetal sheep hearts where 
we identified this measure as correlated to left ventricular end-diastolic pressure. 15  
ZIKV exposure in utero causes placental hypoperfusion.17 Understanding that ZIKV 
exposure can create chronic hypoxic environment for the fetus, we can attempt to 
explain our HRV finding.  
First, albeit temporal profile of Grid Count measure has not been studied in human 
development yet, we can expect with a reasonable confidence based on the behavior 
of other HRV metrics 18 that the overall increase of the gcount metric seen in Figure 1 
reflects system maturation, i.e., increase in complexity.  
Second and most intriguingly, the relationship between ZIKV-exposed and controls is 
inverse compared to what we see ex vivo. In the setting of chronic fetal hypoxia the 
Grid Count appears to serve as memory of in utero hypoxia in the iHRV ex vivo. Ex 
vivo, a removal of hypoxically triggered chronic sympathetic hyperactivity may manifest 
as a rise in Grid Count. Increasing beta-adrenergic drive on cardiac pacemaker cells 
synchronizes their activity in acute mechanistic experiments.19 These findings likely 
hold true for the synchronizing impact chronic sympathetic activity exerts on sinus node 
pacemaker cell coupling in vivo. A withdrawal of such driving input might be expected 
to result in a rebound of uncoupling which would explain rise in Grid Count.  
Conversely, its developmental counterpart in vivo would behave in the opposite, 
because a postnatal intact innervated heart does not experience the rebound response 
we observe ex vivo. Along such line of thought, chronic hypoxia with elevated 
sympathetic activity would continue on postnatally imprinting stronger cardiac 
pacemaker cell coupling and relatively lower Grid Count.  
While the present results are encouraging and classification performance is 
surprisingly high, these findings remain very preliminary and limited due to the small 
sample size and will need to be confirmed and expanded on a much larger cohort. 
A limitation of this pilot study is that there was some variance in ages during ECG 
recording which may have contributed to the difference in HRV measures, because, as 
discussed above, HRV measures may show maturational increase. A counter-
argument to a confounding effect of HRV maturation is that despite more cases of 
microcephaly, head circumference was similar in both groups. 
Another limitation arises from the wide range of gestation when the presence of ZIKV 
symptoms was reported. Future studies will need to show whether such broad 
developmental window of exposure has a variable effect on the HRV phenotype. The 
more interesting is the impact on one particular HRV measure, Grid Count, despite the 
wide developmental window of exposure. Considering that the pacemaker cell activity 
commences as early as 24 days of gestation20, even early Zika exposure may result in 
similar effects we capture compared to late exposure. This is a speculation based on 
the current pilot study and warrants further investigations into how exposure to the 
virus during different trimesters impacts HRV. 
Lastly, two of the ZIKV-exposed babies presented with a microcephaly, i.e., unlike the 
remaining eleven subjects, were clinically symptomatic. We confirmed that these two 
subjects had however no significant impact on our HRV findings.  
In summary, here we show that it is feasible to measure HRV in infants and toddlers 
using a small non-invasive portable ECG device and that such approach may uncover 
memory of in utero exposure to ZIKV. This approach may be useful for future studies 
involving this challenging to examine population.  
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Table 1: Clinical features among cases and controls. 
  
  
CASES 
(TOTAL n = 8) 
CONTROLS 
(TOTAL n = 13) 
 
  N% N% 
p * 
Sex Masculine 7 (87.5%) 7 (53.8%) 
0.173 
Microcephaly 7 (87.5%) 2 (15.3%) 
0.002 
Age At Heart Exam 
  
4-12 Months 5 (62.5%) 0 
0.014 
13-24 Months 3 (37.5%) 13 (100%) 
  
Gestational Age     
  
≤ 36 Weeks 2 (25%) 2 (15.3%) 
0.498 
≥ 37 Weeks 6 (75%) 11 (84.6%) 
  
Head Circumference Z-score 
  
< -3 3 (37.5%) 2 (15.3%) 
0.120 
-3 to -2 1 (12.5%) 0 
  
≥ -2 4 (50%) 11 (84.6%) 
  
Zikv Symptoms 
  
1st Trimester - 3 (23.0%) 
  
2nd Trimester - 6 (46.1%) 
  
3rd Trimester - 4 (30.7%) 
  
 * Fisher Exact Test 
Table 2. Identification of ZIKV exposed / control toddlers using HRV metric Grid Count. 
AUC SEN SPE NPV PPV 
94.51% 85.71% 92.31% 92.31% 85.71% 
 
AUC: Area under the Receiver Operating Curve; SEN: sensitivity; SPE: specificity; NPV: 
negative predictive value; PPV: positive predictive value. 
  
 
Figure 1. The discriminating HRV measure Grid Count (gcount) is shown in hypoxic 
versus normoxic (both in-vivo and ex-vivo) near-term ovine fetuses (presented 
elsewhere 15,16) and ZIKV-exposed versus control human cohorts. The rationale for this 
juxtaposition is the purported chronic hypoxic effect of ZIKV exposure on fetal 
development. See discussion for details.  
Horizontal lines are median and open circles are mean. The box is the interquartile 
range. Outliers are not shown but "whiskers" represent 95%. Red and green * 
represent the two cases of microcephaly in the ZIKV-exposed group. ZIKV versus 
control: p=0.096; ZIKV vs in-vivo hypoxic: p<0.001; Zika control vs in-vivo normoxic: 
p<0.001 (All tests are Wilcoxon rank sum tests). 
